Restoring E-cadherin expression and suppressing metastasis formation and primary tumor growth by 5-aza-2′-deoxycytidine has already been proven in the in vivo model of breast cancer using the MDA-MB435S cell line [119]. The gene discussed is CDH1; the disease is breast carcinoma.